The Chinese healthcare industry is undergoing a significant transformation. With the deepening of medical insurance payment reforms, the accelerated development of commercial health insurance, and the continuous optimization of pharmaceutical supply chains, the potential for synergy among "healthcare, pharmaceuticals, and insurance" is expanding. However, compared to mature markets like the United States, gaps remain in China's healthcare service structure, payment mechanisms, regulatory systems, and market-based operations. The role of commercial health insurance within the medical value chain still needs to be strengthened. Internationally, institutions such as UnitedHealth Group, CVS Health, Kaiser Permanente, and Massachusetts General Hospital have created highly efficient and collaborative healthcare ecosystems through the deep integration of insurance, medical services, and pharmaceutical supply. A systematic study of these international models can help propel China's commercial health insurance from a "reimbursement-based" to a "service-oriented" model, fostering the development of medical service networks, innovation in payment models, and digital advancement, thereby providing a crucial reference for achieving high-quality and sustainable development in China's healthcare system.

We highly recommend the U.S.-based program "Trailblazer - Global Commercial Health Insurance Innovation Executive Bootcamp." Organized by the International Medical Management College, this program connects participants with world-leading academic institutions, insurers, and tech companies in Boston, New York, and San Francisco, including Harvard University, CVS, UHG, Aetna, Kaiser Permanente, and Clover Health. The program will focus on key exchanges covering: 1. A comprehensive deconstruction of core topics integrating academia, industry, and technology; 2. Innovations in medical insurance payment, AI-powered underwriting, chronic disease management, and the integration of insurance and healthcare ecosystems; 3. Exploring models for healthcare-insurance collaboration, data technology, and pathways for payment reform; 4. Providing experience for domestic insurers to address challenges like aging populations, cost pressures, and service transformation. This program is suitable for: 1. Executives and product/innovation leaders from commercial insurance companies; 2. Founders and core teams of insurance technology startups; 3. Business leaders from third-party service providers, medical institutions, and pharmaceutical/medical device companies. For those interested in participating, please contact Instructor Zhu at: 13811349442 (also available on WeChat).